PerProMe: Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Terminated
CT.gov ID
NCT01802164
Collaborator
(none)
5
1
2
25
0.2

Study Details

Study Description

Brief Summary

In patients undergoing laparotomy, the incidence of abdominal wall related complications such as incisional hernia is very high. In particular in patients with peritonitis undergoing laparotomy the incidence of incisional hernia is up to 54.3%. Furthermore, these patients are at great risk for development of postoperative fascial dehiscence.

The gold standard of abdominal wall closure is a running slowly absorbable suture irrespective of the presence of peritonitis. Implantation of an intraperitoneal mesh potentially reduces the incidence of incisional hernia.

In a series of high risk patients in which we implanted non-absorbable intraperitoneal mesh prophylactically we reduced the incidence of incisional hernia down to 3.2%.

Condition or Disease Intervention/Treatment Phase
  • Device: A non-absorbable composite mesh (Ethicon Physiomesh)
N/A

Detailed Description

Background

Incisional hernia is a common complication in visceral surgery and varies between 11 and 26% in the general surgical population [1,2]. An incisional hernia is defined as any abdominal wall gap with or without a bulge in the area of postoperative scar perceptible or palpable by clinical examination or imaging [3]. Overall incidence of incisional hernia at our institution with a follow-up of five years was 14%, whereas in patients undergoing liver transplantation we found an incidence of incisional hernia of 25% in a prospective study [2]. However, patients with peritonitis are at very high risk for the development of incisional hernia. Moussavian et al demonstrated an incidence of incisional hernia of 54.3% after a median follow-up of 6 years in patients undergoing emergency surgery for secondary peritonitis [4]. In patients undergoing surgical therapy for secondary peritonitis, redo surgery because of complications associated with the abdominal wall, such as fascial dehiscence and surgical site infection are frequent. Impaired wound healing in response to the systemic inflammatory response and the high incidence of surgical site infection might render the abdominal wall even more susceptible for incisional hernia, compared with the general surgical population [5,6]. Furthermore, patients with peritonitis undergoing emergency laparotomy develop fascial dehiscence in up to 24.1% [7]. Fascial dehiscence requires reoperation and is associated with a mortality rate up to 44% [8].

Objective

To compare prophylactic mesh implantation to conventional abdominal wall closure in patients undergoing emergency laparotomy for peritonitis.

Methods

Implantation of a non-resorbable intraperitoneal mesh in patients with peritonitis undergoing emergency laparotomy.

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia: A Randomized Controlled Trial
Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Apr 1, 2015
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Conventional abdominal wall closure with mesh implantation

Device: A non-absorbable composite mesh (Ethicon Physiomesh)
To compare prophylactic mesh implantation to conventional abdominal wall closure in patients undergoing emergency laparotomy for peritonitis.

No Intervention: 2

Conventional abdominal wall closure without mesh implantation

Outcome Measures

Primary Outcome Measures

  1. Number of patients with incisional hernia [54 months]

Secondary Outcome Measures

  1. Number of patients with facial dehiscence [54 months]

  2. Mortality [54 months]

  3. Number of patients with surgical site infection [54 months]

  4. Number of patients with intestinal fistula [54 months]

  5. Number of patients with small bowel obstruction [54 months]

  6. Number of patients with postoperative pain [54 months]

  7. Number of patients with low grade mesh infection or chronic subclinical inflammation [54 months]

  8. Number of patients with mesh explantation [54 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with clinical signs of peritonitis

  • Emergency laparotomy or laparoscopy with conversion to laparotomy

  • Patients > 18 years

  • Written informed consent

Exclusion Criteria

  • Previous implanted mesh

  • Incisional hernia present

  • Small bowel obstruction without bowel resection

  • Surgery for cholecystitis

  • Inflammatory bowel disease (Crohn's disease, Ulcerative colitis)

  • Polytrauma patients

  • Pregnant women

  • Women younger than 45 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dep. of visceral and transplant surgery, Berne University Hospital Berne Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne

Investigators

  • Principal Investigator: Guido Beldi, Prof. Dr. med., Dep. of visceral and transplant surgery; Univesrity Hiospital, Berne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT01802164
Other Study ID Numbers:
  • 006/12
First Posted:
Mar 1, 2013
Last Update Posted:
Jun 16, 2015
Last Verified:
Jun 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 16, 2015